Customer Publication
Enter cell line, author or any other phrase or word you would like to search for and click .
![](https://aacr.silverchair-cdn.com/aacr/content_public/journal/mct/15/10/10.1158_1535-7163.mct-15-0986/3/m_2282fig5.jpeg?Expires=1677720008&Signature=jqmnsoCmF8JCO28g-KHbG2BDMs-poX~ZAWPPku19PMJi1k2eAMKVOoGakTLEZNAT-aFIZWOIKl9ZpVDy8SKwzlimP9kbUQqH-xstbO3IMdl2szfqDD00LsB7v6YvDjDTyw4qCkw~6tJfQyZJxEVwHVrNlJw57533zi0d~~oPUNMWJfsjloA01qadObqQGoLpR2SLJrjpgW3ctDgH6-bKmgj~Km0QwcaSjlOkw2Tb~~6Ckor3CqCRkeBI~yFhQyzeCHn56sTb9UCHWBC4Ux3z9DQglBJpfflMsNTMh8zEkpqPgctqzNEif7LLguV~fQvuz0L5aXLq0Qgj~Ou7f2u4Nw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Reversal of Chemoresistance in Ovarian Cancer by Co-delivery of MDR Inhibitors and Paclitaxel Using a Targeted Liposomal Platform
Journal: The faseb journal (2015)
Institution: University of Chicago
Research Areas: Cancer research
Cell Lines: SKOV3 (Human ovarian cancer line)
Summary: Using time-course holographic imaging studies, this cell cycle arrest followed by progression to apoptosis was clearly visualized and confirmed.